Atypical neutrophil alkaline phosphatase associated with impaired neutrophil functions.
We report the case of a healthy young man presenting with atypical neutrophil alkaline phosphatase (NAP) and reduced neutrophil chemotactic activity, but with no susceptibility to infection. NAP activity was low, kinetic parameters were modified and immunoreactive properties and subcellular distribution were abnormal. Neutrophil morphology was normal. A similar pattern was observed in the patient's healthy brother. The profile of the observed anomalies offers some similarity to that previously described in patients with chronic myelogenous leukaemia. However, in the present case, the NAP deficiency with impaired neutrophil function was present in two brothers with no haematological symptoms and is probably related to a non-acquired neutrophil abnormality. This observation of a primary NAP variant reinforces the hypothesis of a direct link between NAP activity and functional properties of neutrophils.
Laharrague
P
P
Laboratoire d'Hématologie, Hôpital Rangueil, Toulouse, France.
Denier
C J
CJ
Grozdea
J
J
Perié
J J
JJ
Corberand
J X
JX
Fillola
G
G
Vergnes
H
H
D000328:Adult; D000469:Alkaline Phosphatase / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000172:deficiency*; D002467:Cell Nucleus / Q000201:enzymology; D002614:Chelating Agents; D002634:Chemotaxis, Leukocyte; D003593:Cytoplasm / Q000201:enzymology; D019281:Dimerization; D004492:Edetic Acid / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D008297:Male; D008854:Microscopy, Electron; D009439:Neuraminidase / Q000494:pharmacology; D009504:Neutrophils / Q000201:enzymology* / Q000502:physiology* / Q000648:ultrastructure; D014508:Urea / Q000494:pharmacology
D002614:Chelating Agents; D004791:Enzyme Inhibitors; D014508:Urea; D004492:Edetic Acid; D000469:Alkaline Phosphatase; D009439:Neuraminidase